FATTY LIVER
Clinical trials for FATTY LIVER explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER trials appear
Sign up with your email to follow new studies for FATTY LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a heart drug help fatty liver patients?
Disease control Recruiting nowThis study tests whether cilostazol, a drug used for blood flow, can reduce fat buildup and scarring risk in the liver. About 50 adults with fatty liver disease (not caused by alcohol) will take the drug or a placebo. The goal is to see if the drug improves ultrasound images and …
Matched conditions: FATTY LIVER
Phase: PHASE1, PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
Can a common drug tame fatty liver? new study hopes so
Disease control Recruiting nowThis study tests whether the drug erdosteine can help people with nonalcoholic fatty liver disease (NAFLD). Researchers will measure changes in liver fat and scarring in 50 adults over the course of the trial. The goal is to see if erdosteine is safe and effective for controlling…
Matched conditions: FATTY LIVER
Phase: PHASE1, PHASE2 • Sponsor: Tanta University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Vitamin B3 shows promise against fatty liver disease in new trial
Disease control Recruiting nowThis study tests whether a daily dose of nicotinamide (a form of vitamin B3) can stop or reverse liver scarring (fibrosis) in people with fatty liver disease. Thirty overweight or obese adults with liver scarring will take either nicotinamide or a placebo for one year. Researcher…
Matched conditions: FATTY LIVER
Phase: PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Fasting study targets 'Lean' fatty liver disease
Disease control Recruiting nowThis study tests whether time-restricted intermittent fasting can reduce liver fat in non-obese adults (BMI 23-30) with non-alcoholic fatty liver disease (NAFLD). Researchers will enroll 25 participants to follow a fasting schedule and measure changes in liver fat using MRI. The …
Matched conditions: FATTY LIVER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
Can new scans replace MRI for fatty liver diagnosis?
Diagnosis Recruiting nowThis study aims to see if newer CT and ultrasound techniques can accurately detect fat and scarring in the liver, compared to the current gold standard, MRI. About 45 adults with liver disease will receive a special CT scan, an MRI, and an ultrasound. If successful, these methods…
Matched conditions: FATTY LIVER
Phase: NA • Sponsor: Duke University • Aim: Diagnosis
Last updated May 14, 2026 12:03 UTC
-
New blood test may catch fatty liver early in At-Risk patients
Knowledge-focused Recruiting nowThis study looks at a blood test called the Enhanced Liver Fibrosis (ELF) test to see if it can detect early fatty liver disease in people at high risk, such as those with diabetes, high blood pressure, or heart disease. Researchers will review medical records from 300 patients t…
Matched conditions: FATTY LIVER
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated May 17, 2026 02:04 UTC
-
18-Year study to unlock secrets of childhood obesity and diabetes
Knowledge-focused Recruiting nowThis study follows 1,500 pregnant women and their children for up to 18 years to understand how a mother's health, lifestyle, and environment during pregnancy affect her child's growth and risk for conditions like obesity, diabetes, and fatty liver. Participants are American Indi…
Matched conditions: FATTY LIVER
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 06, 2026 16:02 UTC